About The Position

The Icahn Genomics Institute and the Mount Sinai Center for Autoimmunity seek a Director of Communication and Strategic Advancement to lead communications, visibility, and strategic advancement across major Mount Sinai initiatives spanning genomics, autoimmunity, cancer, and immunotherapy. Together, these programs bring together genomics, immunology, cancer biology, data science, human disease biology, translational research, clinical partnerships, and therapeutic innovation to advance precision approaches to immune-mediated, malignant, and complex human disease. This is a high-impact, institution-facing role for an energetic scientific communicator who can help define a clear public voice, media presence, donor narrative, and strategic platform for these interconnected areas. The Director will work closely with institute and center leadership, Mount Sinai faculty, institutional communications, development teams, clinical partners, and external stakeholders to communicate scientific and clinical impact across Mount Sinai and beyond. The ideal candidate is a strategic thinker, exceptional writer, and proactive builder who can translate complex biomedical research into compelling narratives for academic, philanthropic, media, policy, industry, patient, and public audiences.

Requirements

  • Strategic thinker
  • Exceptional writer
  • Proactive builder

Responsibilities

  • Lead communications, visibility, and strategic advancement across major Mount Sinai initiatives spanning genomics, autoimmunity, cancer, and immunotherapy.
  • Define a clear public voice, media presence, donor narrative, and strategic platform for these interconnected areas.
  • Work closely with institute and center leadership, Mount Sinai faculty, institutional communications, development teams, clinical partners, and external stakeholders to communicate scientific and clinical impact across Mount Sinai and beyond.
  • Translate complex biomedical research into compelling narratives for academic, philanthropic, media, policy, industry, patient, and public audiences.
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service